DexCom Inc (NAS:DXCM)
$ 131.91 2.2 (1.7%) Market Cap: 52.46 Bil Enterprise Value: 51.28 Bil PE Ratio: 85.10 PB Ratio: 23.26 GF Score: 89/100

Q4 2018 DexCom Inc Earnings Call Transcript

Feb 21, 2019 / 09:30PM GMT
Release Date Price: $36.56 (+0.49%)
Operator

Welcome to the DexCom Fourth Quarter and Full Year 2018 Earnings Release Call. My name is Adrian, and I'll be your operator for today's call. (Operator Instructions) Please note, this conference is being recorded. I'll now turn the call over to Matt Dolan, Vice President, Corporate Development. Please go ahead, sir.

Matthew Dolan
DexCom, Inc. - VP of Corporate Development

Thank you, operator, and welcome to DexCom's Fourth Quarter 2018 Earnings Call. We will begin our prepared remarks with Kevin Sayer, DexCom's Chairman, President and CEO, who will provide a summary of the quarter and fiscal year. This will be followed by a review of our financials and 2019 outlook from Quentin Blackford, our Executive Vice President and CFO; and then a strategic update from Steve Pacelli, our Executive Vice President of Strategy and Corporate Development. Following our prepared remarks, we'll open up the call for your questions. (Operator Instructions) With that, let's review our safe harbor statement.

Some of the statements that we will make in today's call may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot